AbbVie 2014 Annual Report Download - page 158

13NOV201221352027
2014 Outstanding Equity Awards at Fiscal Year End
................................................................................................................................................................................................................................................................................................................................................................................................
The following table summarizes the outstanding AbbVie equity awards held by the NEOs at year end.
R. Gonzalez 36,733 24.2082 02/17/2021 19,800(3) $1,295,712
71,533 35,767(3) 29.2265 02/16/2022 171,813(3) 11,243,443
175,477 350,953(3) 35.8800 02/13/2023 162,960(3) 10,664,102
281,030(3) 51.4200 02/19/2024
M. Severino 74,309(3) 54.4400 06/01/2024 141,625(3) 9,267,940
C. Alban 45,800 24.2082 02/17/2021 8,900(3) 582,416
32,067 16,033(3) 29.2265 02/16/2022 35,521(3) $2,324,494
38,610 77,220(3) 35.8800 02/13/2023 37,800(3) 2,473,632
81,500(3) 51.4200 02/19/2024 47,260(3) 3,092,694
L. Schumacher 66,300 28.8628 02/14/2018 14,733(3) 964,128
38,940 28.1251 02/19/2019 59,202(3) 3,874,179
42,533 28.3122 02/18/2020 47,486(3) 3,107,484
38,333 24.2082 02/17/2021 54,590(3) 3,572,370
53,200 26,600(3) 29.2265 02/16/2022
48,504 97,006(3) 35.8800 02/13/2023
94,140(3) 51.4200 02/19/2024
W. Chase 6,600 27.2940 02/15/2017 3,633(3) 237,744
25,500 28.8628 02/14/2018 44,401(3) 2,905,601
12,800 28.1251 02/19/2019 37,800(3) 2,473,632
13,400 28.3122 02/18/2020 53,770(3) 3,518,709
19,000 24.2082 02/17/2021
13,067 6,533(3) 29.2265 02/16/2022
38,610 77,220(3) 35.8800 02/13/2023
92,740(3) 51.4200 02/19/2024
(1) When AbbVie separated from Abbott on January 1, 2013, outstanding Abbott equity awards generally converted
into adjusted awards based on Abbott common shares and AbbVie common stock (except to the extent prohibited
by local law or with respect to certain awards described below).
Holders of Abbott restricted shares generally retained those awards and received restricted stock of AbbVie in an
amount that reflected the distribution to Abbott shareholders, except for Abbott restricted stock awards granted on
December 1, 2012 that converted in full into AbbVie restricted stock awards as of the Separation, as described in
note (e) to footnote (3) below. Such awards are subject to substantially the same terms, vesting conditions and
other restrictions that applied to the original Abbott awards immediately before the distribution.
Each Abbott stock option was converted into an adjusted Abbott stock option and an AbbVie stock option, with
adjustments to the stock option exercise prices that were intended to preserve the value of the original Abbott
award as measured immediately before and immediately after the distribution. Each such adjusted Abbott stock
option and AbbVie stock option is subject to substantially the same terms, vesting conditions, post-termination
exercise rules and other restrictions that applied to the original Abbott stock option immediately before the
distribution.
38 2015 Proxy Statement
Option Awards(1)(2) Stock Awards(1)
Equity
Equity Incentive
Incentive Plan Awards:
Plan Awards: Market or
Number of Payout Value
Number of Number of Market Unearned of Unearned
Securities Securities Number of Value of Shares Shares
Underlying Underlying Shares of Shares of or Other or Other
Unexercised Unexercised Option Option Stock That Stock That Rights That Rights That
Options (#) Options (#) Exercise Expiration Have Not Have Not Have Not Have Not
Name Exercisable Unexercisable Price ($) Date Vested (#) Vested ($) Vested (#) Vested ($)
EXECUTIVE COMPENSATION